Old Web
English
Sign In
Acemap
>
authorDetail
>
Tina S. Cleary
Tina S. Cleary
Ophthalmology
Ranibizumab
Medicine
in patient
Bevacizumab
5
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
2017
Kendra A. Klein
Tina S. Cleary
Elias Reichel
Show All
Source
Cite
Save
Citations (19)
Effects of Ranibizumab on Exudative Disciform Scars
2009
Ophthalmic Surgery Lasers & Imaging
Fatima K Ahmad
Michael Morley
Anna Berry
Torsten W Wiegand
Jeffrey S. Heier
Eleanor F Morley
Thuss Sanguansak
Trexler M. Topping
Albert R. Frederick
Delia N Sang
Mark Hughes
Tina S. Cleary
Show All
Source
Cite
Save
Citations (1)
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
2009
Retina-the Journal of Retinal and Vitreous Diseases
Jeffrey S. Heier
Carl C. Awh
Brandon G. Busbee
L David Waterbury
Paul E. Daniel
Glenn L. Stoller
Tina S. Cleary
Show All
Source
Cite
Save
Citations (36)
Ranibizumab Treatment of Patients With Neovascular AMD Previously Treated With Intravitreal Bevacizumab
2007
Investigative Ophthalmology & Visual Science
Jackie K. Nguyen
Jeffrey S. Heier
Tina S. Cleary
Michael Morley
Albert R. Frederick
Trexler M. Topping
D. A. Eichenbaum
A. Berry
Show All
Source
Cite
Save
Citations (1)
Comparison of Vitreous PGE2 Concentrations of Ketorolac 0.4%, Bromfenac 0.09%, and Nepafenac 0.1% in Patients Undergoing Vitrectomy
2007
Investigative Ophthalmology & Visual Science
Brandon G. Busbee
Jeffrey S. Heier
D. Waterbury
Carl C. Awh
Glenn L. Stoller
Tina S. Cleary
P Daniels
Show All
Source
Cite
Save
Citations (2)
1